0.22 Micron Filtration for Research Peptides: Scope and Limits

A 0.22 micron (µm) rating describes a membrane filtration class, not a guarantee that every organism or contaminant will be removed. In research peptide work, assess microbial retention separately from analyte recovery, adsorption and device hold-up. This guide focuses on those analytical limits; it does not establish sterility of any Vertex product.

For Research Use Only. Not for human or veterinary use. Nothing here describes preparation or administration for people or animals.

TL;DR

• Sterilizing-grade membranes often have nominal ratings of 0.2 or 0.22 µm. Retention requires validation for the filter and process; the rating alone does not establish removal of viruses, mycoplasma or endotoxins.
• Pore rating decides what is excluded. Membrane chemistry decides what is lost. Reported adsorption losses depend on the sequence, membrane and experimental conditions; a published percentage is not a correction factor for another sample.
• Hold-up volume and first-fraction effects matter most on small, dilute samples, so validate recovery for each peptide with your own analytical method.
• Request lot-level Certificates of Analysis (COAs) and batch documentation, because a filter does not substitute for verified identity and purity.

Table of Contents

• What a 0.22 micron filter actually does
• What passes through a 0.22 micron filter
• When filtration is appropriate for a research solution
• Adsorption: the loss that does not show on the package
• Choosing a membrane
• Known limits of sterilizing-grade filters
• Documentation to request alongside filtered or sterile materials
• Our perspective
• Research-grade materials with batch documentation
• FAQ
• Sources

What a 0.22 micron filter actually does

A membrane separates material through its pore structure and surface interactions. Microbial retention depends on the organism, membrane integrity and operating conditions. Retention does not kill organisms; handle used devices under the laboratory’s validated biosafety and disposal procedures.

The nominal pore rating does not mean every pore is exactly 0.22 µm. Use the manufacturer’s retention validation and compatibility data for the particular membrane, sample and process. An analytical filter is not automatically a sterilizing-grade device.

The FDA aseptic-processing guidance treats 0.2 and 0.22 µm as interchangeable nominal ratings and describes microbial challenge validation under worst-case process conditions. This is a reference for the distinction between rating and validated retention, not a statement that RUO catalog products meet pharmaceutical manufacturing requirements.

Verifying the pore rating

Bubble point and other integrity tests must use the manufacturer’s specifications for the membrane, wetting fluid, temperature and device. There is no single pressure range that validates every 0.22 µm membrane, and an integrity result alone does not establish peptide recovery or endotoxin removal.

What passes through a 0.22 micron filter

Do not infer removal of the following from a nominal pore rating:

• Viruses. Virus removal requires a separately validated process; a 0.22 µm rating is not evidence of viral clearance.
• Mycoplasma. Some small or deformable organisms can pass conventional membranes. Select and validate a process against the organisms relevant to the assay.
• Endotoxins. Bacterial retention does not demonstrate endotoxin removal. Any removal claim needs appropriate process validation and a separate assay with matrix-interference controls.
• The peptide itself. Peptides are far smaller than the pore, so size exclusion does not separate a peptide from its solvent. Filtration may remove particulates or retain microorganisms under validated conditions; it does not by itself establish sterility or peptide chemical purity.

Dissolved synthesis impurities are not reliably removed by a 0.22 µm membrane. Distinguish filtration from purification and from analytical identity testing.

When filtration is appropriate for a research solution

Filtration suits heat-sensitive aqueous solutions that cannot be autoclaved. It is a poor fit for suspensions or particulate-laden fluids that clog the membrane, for viscous liquids beyond the device’s pressure rating, and for solutions in which the membrane adsorbs the active ingredient.

A short decision list for assay design:

1. Is sterility required for the assay? Cell-based work typically needs it. Many analytical workflows, such as HPLC sample preparation, use filtration mainly to remove particulates and protect columns and needles.
2. How dilute is the analyte? Dilute solutions lose proportionally more to the membrane.
3. What is the sample volume? Small volumes make hold-up losses significant.
4. What is the solvent? Membrane compatibility with organic content determines which material you can use.
5. Can you quantify before and after? If not, you cannot know what the filtered solution contains.

Adsorption: the loss that does not show on the package

Peptides adsorb to filter surfaces, and the effect is generally worst in dilute solutions. A 2025 analysis of adsorption data from more than 100 peptide compounds, presented as an ISSX poster on desorption strategies, found significant adsorption in 32.8% of the peptides tested. Adsorption was highest on 0.22 µm membranes (PES or PVDF) at 10 to 20%, followed by plastic syringes at 5 to 10%, while glass containers showed less than 2%. The same work reported 10 to 20% loss on membranes at low concentration and 2 to 5% at high concentration. These are findings reported in a conference poster, not a universal recovery specification or Vertex test results. The accompanying illustration summarizes that poster and must not be used to correct measurements from another peptide or device.

Charge matters too. A chromatography case study on β-endorphin (1-31) found that significant loss occurred on a cellulose filter because the strongly positive molecule was retained, and concluded that the filtration step should be tested with each peptide.

Two practical consequences follow:

• Two filters with the same 0.22 µm rating can return different amounts of analyte. Rating describes exclusion. Surface chemistry describes adsorption.
• A concentration-response experiment built on filtered stock inherits any filtration loss. If the stock concentration is assumed rather than measured after filtration, the resulting curve carries that error.

Control carryover using a cleaning procedure validated for the laboratory’s equipment and analytes. A commercial cleaning product link is not evidence of recovery or decontamination performance for the method.

First-fraction and hold-up volume

Every filter device retains some liquid, partly in the wetted membrane and partly in the housing’s dead space. On a small sample, that can be a large share of the volume. Also, the first liquid to meet an unsaturated membrane tends to give up the most peptide, so the leading fraction can be the most depleted. Common mitigations in method development include discarding or pre-conditioning a defined first portion, using the same fraction cut for every sample, and measuring the filtrate against an unfiltered reference.

Choosing a membrane

Membrane choice should follow solvent compatibility first, then adsorption behavior. The table summarizes general laboratory considerations for common materials. Always confirm against the manufacturer’s chemical compatibility chart for your solvent.

Membrane structure also affects throughput. A 2022 peer-reviewed comparison of hydrophilic PVDF and PES sterile filters found both passed the bacterial challenge test, but the filter with an asymmetric morphology and smaller mean pore diameter had higher permeability and capacity, along with a higher fouling tendency with protein under constant pressure. The same study notes that 100% protein transmission can be achieved through 0.22 µm filters in sterile filtration, yet protein aggregates or pore blocking can cause fouling and product loss.

Known limits of sterilizing-grade filters

No membrane is a guarantee in every circumstance. Merck’s technical note on small organisms describes incidents of microbial penetration of 0.2 and 0.22 µm filters, attributed to grow-through, deformable organism forms and exceeding the filter’s clearance capacity. Organisms of specific concern include Burkholderia cepacia, Ralstonia pickettii and Pseudomonas species. The same document states that regulators expect processing time limits for sterilizing filtration steps to be set and validated, which is a reminder to avoid holding filtered solutions or running filters for extended periods without a validated basis.

Good practice in a research lab therefore combines the filter with other controls: clean handling, defined hold times, appropriate storage and documented lot traceability. Our overview of regulated peptide handling best practices covers the surrounding workflow.

Documentation to request alongside filtered or sterile materials

Filtration is a handling step. Quality begins upstream, with what the material is and how pure it is. When you evaluate a source, look for:

• A batch-specific COA tied to the lot you receive, not a generic sheet.
• Independent third-party laboratory results for identity and purity.
• Clear statements of what sterile filtration claims cover for that lot.
• Storage and stability information consistent with your intended use.

We set out our expectations in detail in requiring lot-level COAs for 0.22 micron sterile filtration, and our peptide vendor evaluation criteria give a checklist for procurement teams.

Our perspective

Treat filtration as an experimental variable. A nominal pore rating alone cannot establish a sterile result, and recovery may change with membrane chemistry, peptide concentration and the sample matrix. Record these factors alongside the analytical result.

Vertex Labs supplies research-use-only materials. Review the selected product presentation and its available batch-specific COA; documentation availability and reported results vary by lot. A published purity standard does not replace the findings of an individual laboratory report. A starting-material COA does not prove that every subsequent difference is caused by filtration; include matched controls for storage, handling and measurement variability.

We recommend that laboratories quantify before and after filtration for each peptide, record the membrane material and device size, and keep the lot number with the data. Those records make results reproducible and make procurement decisions easier to defend.

Vertex Labs Editorial Team

Research-grade materials with batch documentation

Vertex Labs supplies research-use-only materials. Review the selected product presentation and its available batch-specific COA; documentation availability and reported results vary by lot. A published purity standard does not replace the findings of an individual laboratory report. Custom synthesis and bulk procurement may be discussed on request; feasibility, tests and documentation must be confirmed for the individual order.

Browse the research compound catalog or visit Vertex Labs to review product lines and request documentation for the lot you need. For Research Use Only. Not for human or veterinary use.

FAQ

What can pass through a 0.22 micron filter?

Most viruses, mycoplasma, and endotoxins can pass, along with dissolved molecules such as peptides, because retention is based on size. Do not infer contaminant removal or sterility from the nominal rating; separate validation and testing are needed for the intended endpoint.

Should research peptide solutions be filtered?

It depends on the assay. Filtration is useful for heat-sensitive aqueous solutions that need sterility or particulate removal, but the membrane can adsorb analyte, especially at low concentration. Measure the peptide before and after filtering with your analytical method, and choose the membrane accordingly.

What are the benefits and limits of a 0.22 micron filter?

The potential benefit is microbial or particulate retention without heat when the filter and process have been validated for that purpose. The limits are passage of smaller contaminants, adsorptive loss, hold-up volume and the need for validated processing times. Filtration also does not improve peptide purity.

Checking Vertex batch evidence

Open the current catalog and COA directory, then match the selected presentation and vial lot to the complete laboratory report. For example, the MOTS-C product page lists separate reports for its 20 mg and 40 mg presentations. A report for one presentation does not verify another or establish which lot is currently shipping. Purity results do not establish sterility, counterion composition, accreditation or clinical suitability unless those matters are separately documented.

For lawful laboratory research only. Purchasers must meet Vertex’s eligibility requirements, including age 21 or older. Sales are directed to the United States and Puerto Rico. Not for human or veterinary use.

Sources

• Syringe Filters, Sigma-Aldrich technical article
• Filtration Resource Library, Thermo Fisher Scientific
• Sterilization by Liquid Filtration, Tuttnauer
• An Over View of Sterile Filtration Validation, JSM Central
• A guide to sterile filtration solutions, Atlas Copco
• Desorption Strategies in Peptide Formulation Preparation, ISSX 2025 poster
• Inaccuracies in Quantification of Peptides, Chromatography Online
• Comparative Evaluation of the Performance of Sterile Filters, PMC
• Retention of Small Organisms by Durapore 0.22 µm Filters, Merck Millipore

Recommended

• Require Lot Level COAs for 0.22 Micron Sterile Filtration
• current research resources